Ad Header

PharmaLive

Slogan

The Pulse of the Pharmaceutical Industry

  • Filter By Category

  • Filter By Author

Alcon Spin-Off From Novartis: April 9, 2019

Novartis will officially spin its Alcon eye-care business off into a separately traded standalone business unit on April 9, 2019.

Read More »

FCB Health Network Launches New Offering: Solve(d)

FCB Health Network chief commercial officer Michael Guarino announced the launch of Solve(d), a new offering that enhances the evidence-based planning and execution of clients’ healthcare marketing strategies and tactics.

Read More »

Novartis AG Pledges to Nearly Triple Biosimilar Drugs on Market By 2020

Switzerland’s Novartis pledged to nearly triple its number of biosimilar drugs on the market by 2020, raising its bet that cheaper versions of blockbuster cancer and immune system medicines will snatch billions in rivals’ profits. Novartis’s Sandoz generics unit aims to be selling eight biosimilars, compared with three now, as patents on original drugs expire. […]

Read More »

The Evolving Role of Global Teams in a Digital World

Much has been written about the impact of digital media on the life sciences industry. However, an area less discussed is how to maximize that impact globally, and in particular how to organize for success.

Read More »

Ad Right Top

MedAdNews

Extensive pharmaceutical business and marketing intelligence. For back issues, please contact MDAD@kmpsgroup.com.

June 2019 Focus: Payer access, biotech/biopharma, DTC, rare diseases, and more!

Subscribe

Ad Right Bottom